Chronic Hepatitis B
Chronic Hepatitis B is a long-term viral infection of the liver caused by the hepatitis B virus (HBV), which can lead to serious liver problems, including cirrhosis and liver cancer.
We are investigating the safety and effects of new antibodies for people with hepatitis B. This study aims to learn more about how these treatments may help manage the disease.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Hepatitis B is a long-term viral infection of the liver caused by the hepatitis B virus (HBV), which can lead to serious liver problems, including cirrhosis and liver cancer.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.